| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Center for Neuro-Oncology and the Laboratory of Cancer Pharmacology, Dana-Farber Cancer Institute [T. T., H. A. F.], The Department of Surgery, Children's Hospital [Y. C., J. F.], Harvard Medical School, Boston, Massachusetts 02115, and the Institute of Genomic Research, Karolinska Institute, Stockholm, Sweden [Y. C.]
Despite recent advances in neurosurgery, radiation, and chemotherapy, the prognosis of patients with malignant gliomas remains dismal. Based on the observation that solid tumor growth is angiogenic dependent, and gliomas are among the most angiogenic of all tumors, therapeutic strategies aimed at inhibiting angiogenesis are theoretically attractive. Angiostatin, an internal peptide fragment of plasminogen, has recently been shown to potently inhibit endothelial proliferation in vitro and tumor growth in vivo. Long-term systemic delivery of proteins, however, poses a number of difficult logistic and pharmacological problems and may not be necessary or optimal for treating locally aggressive tumors such as gliomas. We now demonstrate that retroviral and adenoviral vectors that transduce the angiostatin cDNA can be used to inhibit endothelial cell growth in vitro and angiogenesis in vivo. Vector-mediated inhibition of tumor-associated angiogenesis results in increased apoptotic tumor cell death, leading to inhibition of tumor growth. These studies support a potential role of vector-mediated transduction of the cDNA encoding angiostatin as a potential novel therapeutic strategy for the treatment of malignant brain tumors and confirm the antitumor activity of angiostatin and the concept of dormancy therapy.
1 To whom requests for reprints should be addressed, at Center for Neuro-Oncology, Dana 1234, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115. Phone: (617) 632-2166; Fax: (617) 632-4773.
Received 3/ 9/98. Accepted 6/ 2/98.
This article has been cited by other articles:
|
|
 |
|
  H.-M. Cho, J. D. Rosenblatt, Y.-S. Kang, M. L. Iruela-Arispe, S. L. Morrison, M. L. Penichet, Y.-G. Kwon, T.-W. Kim, K. A. Webster, H. Nechustan, et al. Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein Mol. Cancer Ther., June 1, 2005; 4(6): 956 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Daly, A. Makris, M. Reed, and C. E. Lewis Hemostatic Regulators of Tumor Angiogenesis: A Source of Antiangiogenic Agents for Cancer Treatment? J Natl Cancer Inst, November 19, 2003; 95(22): 1660 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Fine, P. Y. Wen, E. A. Maher, E. Viscosi, T. Batchelor, N. Lakhani, W. D. Figg, B. W. Purow, and C. B. Borkowf Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas J. Clin. Oncol., June 15, 2003; 21(12): 2299 - 2304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Saimura, E. Nagai, K. Mizumoto, N. Maehara, Y. A. Minamishima, M. Katano, K. Matsumoto, T. Nakamura, and M. Tanaka Tumor Suppression through Angiogenesis Inhibition by SUIT-2 Pancreatic Cancer Cells Genetically Engineered to Secrete NK4 Clin. Cancer Res., October 1, 2002; 8(10): 3243 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Scappaticci Mechanisms and Future Directions for Angiogenesis-Based Cancer Therapies J. Clin. Oncol., September 15, 2002; 20(18): 3906 - 3927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gonzalez-Gronow, G. Gawdi, and S. V. Pizzo Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells Blood, May 29, 2002; 99(12): 4562 - 4567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Izawa, P. Sweeney, P. Perrotte, D. Kedar, Z. Dong, J. W. Slaton, T. Karashima, K. Inoue, W. F. Benedict, and C. P. N. Dinney Inhibition of Tumorigenicity and Metastasis of Human Bladder Cancer Growing in Athymic Mice by Interferon-{beta} Gene Therapy Results Partially from Various Antiangiogenic Effects Including Endothelial Cell Apoptosis Clin. Cancer Res., April 1, 2002; 8(4): 1258 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-I Ma, P. Guo, J. Li, S.-Z. Lin, Y.-H. Chiang, X. Xiao, and S.-Y. Cheng Suppression of Intracranial Human Glioma Growth after Intramuscular Administration of an Adeno-associated Viral Vector Expressing Angiostatin Cancer Res., February 1, 2002; 62(3): 756 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Indraccolo, M. Morini, E. Gola, F. Carrozzino, W. Habeler, S. Minghelli, L. Santi, L. Chieco-Bianchi, Y. Cao, A. Albini, et al. Effects of Angiostatin Gene Transfer on Functional Properties and in Vivo Growth of Kaposi's Sarcoma Cells Cancer Res., July 1, 2001; 61(14): 5441 - 5446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gyorffy, K. Palmer, T. J. Podor, M. Hitt, and J. Gauldie Combined Treatment of a Murine Breast Cancer Model with Type 5 Adenovirus Vectors Expressing Murine Angiostatin and IL-12: A Role for Combined Anti-Angiogenesis and Immunotherapy J. Immunol., May 15, 2001; 166(10): 6212 - 6217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ding, J. Z. Sun, B. Fenton, W. M. Liu, P. Kimsely, P. Okunieff, and W. Min Intratumoral Administration of Endostatin Plasmid Inhibits Vascular Growth and Perfusion in MCa-4 Murine Mammary Carcinomas Cancer Res., January 1, 2001; 61(2): 526 - 531. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. E. Koch The role of angiogenesis in rheumatoid arthritis: recent developments Ann Rheum Dis, November 1, 2000; 59(90001): i65 - 71. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liu, L. Liu, W. F. Anderson, R. W. Beart, E. M. Gordon, and F. L. Hall Incorporation of Tumor Vasculature Targeting Motifs into Moloney Murine Leukemia Virus Env Escort Proteins Enhances Retrovirus Binding and Transduction of Human Endothelial Cells J. Virol., June 1, 2000; 74(11): 5320 - 5328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Sacco, M. Caniatti, E. M. Cato, A. Frattini, G. Chiesa, R. Ceruti, F. Adorni, L. Zecca, E. Scanziani, and P. Vezzoni Liposome-delivered Angiostatin Strongly Inhibits Tumor Growth and Metastatization in a Transgenic Model of Spontaneous Breast Cancer Cancer Res., May 1, 2000; 60(10): 2660 - 2665. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Gorrin-Rivas, S. Arii, M. Furutani, M. Mizumoto, A. Mori, K. Hanaki, M. Maeda, H. Furuyama, Y. Kondo, and M. Imamura Mouse Macrophage Metalloelastase Gene Transfer into a Murine Melanoma Suppresses Primary Tumor Growth by Halting Angiogenesis Clin. Cancer Res., May 1, 2000; 6(5): 1647 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ambs, S. Dennis, J. Fairman, M. Wright, and J. Papkoff Inhibition of Tumor Growth Correlates with the Expression Level of a Human Angiostatin Transgene in Transfected B16F10 Melanoma Cells Cancer Res., November 1, 1999; 59(22): 5773 - 5777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. I. Meneses, L. E. Abrey, K. A. Hajjar, S. H. Gultekin, R. M. Duvoisin, K. I. Berns, and M. R. Rosenfeld Simplified Production of a Recombinant Human Angiostatin Derivative That Suppresses Intracerebral Glial Tumor Growth Clin. Cancer Res., November 1, 1999; 5(11): 3689 - 3694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Harada, K. Nakagawa, S. Iwata, M. Saito, Y. Kumon, S. Sakaki, K. Sato, and K. Hamada Restoration of Wild-Type p16 Down-Regulates Vascular Endothelial Growth Factor Expression and Inhibits Angiogenesis in Human Gliomas Cancer Res., August 1, 1999; 59(15): 3783 - 3789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-R. Chen, D. Kumar, S. A. Stass, and A. J. Mixson Liposomes Complexed to Plasmids Encoding Angiostatin and Endostatin Inhibit Breast Cancer in Nude Mice Cancer Res., July 1, 1999; 59(14): 3308 - 3312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Griscelli, H. Li, C. Cheong, P. Opolon, A. Bennaceur-Griscelli, G. Vassal, J. Soria, C. Soria, H. Lu, M. Perricaudet, et al. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model PNAS, June 6, 2000; 97(12): 6698 - 6703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Papetti and I. M. Herman Mechanisms of normal and tumor-derived angiogenesis Am J Physiol Cell Physiol, May 1, 2002; 282(5): C947 - C970. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
